OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2021
(2)
2018
(2)
2022
(1)
2016
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.
Not available
S-EPMC4981978
|
biostudies-literature
Cite
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.
Not available
S-EPMC3595426
|
biostudies-literature
Cite
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Not available
S-EPMC6075846
|
biostudies-literature
Cite
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Not available
S-EPMC5773840
|
biostudies-literature
Cite
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
Not available
S-EPMC7429266
|
biostudies-literature
Cite
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995
|
biostudies-literature
Cite
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Not available
S-EPMC8652887
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets